You are here: Industry Insights > AI drug

News List

CTFH and Insilico Medicine Enter Al Drug Discovery Collaboration Focused On Accelerating First-in-Class Therapeutics, Worth Up to $200 million En-CPhI.CN
October 11, 2019
Insilico Medicine, a company developing an end-to-end drug discovery pipeline utilizing the latest advances in deep learning ...
Sensyne Health and Bayer partner on AI drug development pharmaceutical-technology
August 05, 2019
Sensyne Health, a UK-based clinical artificial intelligence (AI) technology firm, has collaborated with German pharmaceutical company Bayer to accelerate the development of new heart therapies.
Exscientia and GT Apeiron form AI drug discovery alliance pharmaceutical-technology
June 13, 2019
Exscientia has entered a multi-target partnership with China-based GT Apeiron Therapeutics.
Bayer partners with Imperial College London for AI drug discovery pharmaceutical-technology
December 21, 2018
Germany-based Bayer Pharmaceuticals has partnered with Imperial College London to leverage artificial intelligence (AI) to drive drug discovery for heart disorders....